Transgene

Share Issue/Capital Change • Jan 17, 2023

PRESS RELEASE

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2022

Strasbourg, January 17, 2023 – 05:45 pm CET

Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2022, the following resources were managed through the liquidity account:

• 286,436 shares
• € 123,251.00

In the second half of 2022, a total of:

Purchases	230,148 shares	€ 467,081	800 market transactions
Sales	173,969 shares	€ 362,798	714 market transactions

It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:

Cash balance of the liquidity contract: € 500,000.00

At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:

• 164,183 shares
• € 246,158.00

Contacts

Transgene:

Jean-Philippe Del CFO +33 (0)3 88 27 91 00 investorrelations@transgene.fr